Pharmacist Suspended for Convictions Related to Controlled Drugs
Date of Decision: November 28, 2019
Registrant's Role: Pharmacist
Allegations:
- Conviction for possession with intent to supply a Controlled Drug of Class C (Tramadol)
- Conviction for possession with intent to supply a Controlled Drug of Class C (Zolpidem)
- Conviction for possession with intent to supply a Controlled Drug of Class C (Zopiclone)
- Conviction for possession of a Controlled Drug of Class C (Lorazepam)
Outcome: Suspension extended for a further period of six months
GPhC Standards Breached:
- Standard 6 – Act with honesty and integrity
- Standard 9 – Demonstrate leadership
Case Summary
Allegations
The registrant, a pharmacist, was convicted on 30 November 2016 of several offences under the Misuse of Drugs Act 1971. Specifically, the convictions included possession with intent to supply Class C controlled substances—Tramadol, Zolpidem, and Zopiclone—as well as simple possession of Lorazepam. These charges arose from the registrant’s personal conduct and directly implicated her professional responsibilities in handling controlled drugs. The principal Fitness to Practise Committee concluded that she accessed these medications solely due to her role as a pharmacist and exploited that access, fundamentally breaching public trust.
Findings
Continue Reading the Full Case
This case was published more than two weeks ago. A premium subscription is required to read the complete case summary.
- Full allegations considered by the GPhC/PSNI
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
The original determination document is available to registered users.